The delisting move of Fresenius Kabi Oncology has raised eyebrows as only a few months back the company did a OFS.
SES Governance , a non profit Corporate Governance Research and Proxy Advisory firm has shared it’s analysis of the delisting.
[gview file=”https://alphaideas.in/wp-content/uploads/2013/04/SES-Fresenius-Kabi-Oncology-Research-April-20131.pdf”]
Discover more from Alpha Ideas
Subscribe to get the latest posts sent to your email.
One reply on “Analysis of Delisting of Fresenius Kabi Oncology”
thank you for providing this link.
great information for fresenius kabi shareholders.